Patent Yard Sign in
Canadian application, no grantCanada

Syringe system

CA 2111985 A1 · Owner: Novo Nordisk A/S · Inventors: Jorgensen, Peter Nissen; Bonnichsen, Frits Frydendal

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

An insulin injection system comprises a pen shaped syringe with a cartridge containing insulin, and an injection needle. The needle is a G 30 needle and the insulin is a type which may freely flow through a G 30 needle. When the insulin is the type comprising suspended crystals the maximal dimension of any crystal is 15 µm.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 2, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 2, 2012.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 2, 2014.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 2, 1992
GrantedNo grant recorded
Term endedJuly 2, 2012
Patent numberCA 2111985 A1
Classification (IPC)A61M5/32 +2 more

Timeline

Timeline From CIPO dates

1993199519971999200120032005200720092011Application filedJuly 2, 1992Term endedJuly 2, 2012

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.